Advancing Oncology Imaging Beyond RECIST 1.1

Harnessing the power of AI and ML using Radiomics and other Multimodal Data for Predicting Long-Term Outcomes

Learn more below.

Previous
Previous

Radiopharmaceuticals & Future Trends: Highlighting FAPI and Granzyme B Imaging

Next
Next

Imaging-Based Tools to Enhance Signals of Efficacy in Early Stages of Oncology Clinical Development